Amedisys, Inc. (AMED)
Aug 14, 2025 - AMED was delisted (reason: acquired by UNH)
100.99
+0.01 (0.01%)
Inactive · Last trade price on Aug 14, 2025
Amedisys Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Amedisys stock had an average target of 100.67, with a low estimate of 100 and a high estimate of 101.
Price Target: $100.67 (-0.32%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 16, 2025.
Analyst Ratings
The average analyst rating for Amedisys stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 5 | 5 | 5 | 5 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $100 | Buy | Reiterates | $100 | -0.98% | Apr 16, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +0.01% | Mar 4, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +0.01% | Feb 12, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $101 | Strong Buy → Hold | Downgrades | $101 | +0.01% | Jul 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +0.01% | Jul 25, 2024 |
Financial Forecast
Revenue This Year
2.50B
from 2.35B
Increased by 6.29%
Revenue Next Year
2.63B
from 2.50B
Increased by 5.29%
EPS This Year
4.88
from 1.31
Increased by 272.34%
EPS Next Year
5.27
from 4.88
Increased by 8.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.6B | 2.8B | |
| Avg | 2.5B | 2.6B | |
| Low | 2.4B | 2.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 11.4% | 11.0% | |
| Avg | 6.3% | 5.3% | |
| Low | 1.2% | -1.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.53 | 5.96 | |
| Avg | 4.88 | 5.27 | |
| Low | 4.49 | 4.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 322.4% | 22.3% | |
| Avg | 272.3% | 8.1% | |
| Low | 242.6% | -6.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.